Prelude Therapeutics PRLD
NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Operating Margin (2024 - 2026)

Updated

Prelude Therapeutics (PRLD) recorded Operating Margin of -270.93% in Q2 2026, up 38.61 percentage points from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Operating Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Prelude Therapeutics' Operating Margin came in at -300.56% as of Jun 30, 2026, up 1628.11 percentage points year-over-year; for FY2025, it came in at -861.33%, up 1134.58 percentage points from FY2024.

  • Across earlier years, Operating Margin came in at -1995.91% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -309.54% (Q1 2026), -307.59% (Q4 2025) and -314.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - -270.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -270.93%
Mar 31, 2026 -309.54%
Dec 31, 2025 -307.59%
Sep 30, 2025 -314.12%
Dec 31, 2024 -845.78%
Sep 30, 2024 -1,145.87%
API Access

Prelude Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PRLD&period=max&api_key=YOUR_API_KEY